Unlimited Bio CTO Anna Vakhrusheva returned from the Aging Research and Drug Discovery (ARDD) Conference 2025, one of the most prestigious global events in longevity science, bringing together Nobel laureates, pharma leaders, and cutting-edge biotech innovators.
Dr. Vakhrusheva described the program as intense and thought-provoking, with standout moments including:
“ARDD is perhaps the most image-shaping conference in longevity,” Anna Vakhrusheva said. “It bridges pharma, biotech, and academia, showcasing both rigorous science and daring innovation.”
Her reflections underscored ARDD’s role as a global stage where science, biotech, and pharma converge to accelerate progress in healthy longevity.
Read the full post on Anna's LinkedIn.
Dr. Vakhrusheva described the program as intense and thought-provoking, with standout moments including:
- Retrotransposons & Fertility. Dr. Andrei Seluanov presented data showing that knockdown of LINE1 retrotransposons in mice reduced inflammation, extended lifespan, and even preserved fertility beyond typical reproductive windows — sparking interest in reverse transcriptase inhibitors as a potential longevity pathway.
- Biohacker Self-Experimentation. Dr. Vakhrusheva spoke with a biohacker who had injected himself with hTERT gene therapy (10¹⁵ viral particles), claiming improved vitality and even increased libido — a striking example of bold experimentation in the field.
“ARDD is perhaps the most image-shaping conference in longevity,” Anna Vakhrusheva said. “It bridges pharma, biotech, and academia, showcasing both rigorous science and daring innovation.”
Her reflections underscored ARDD’s role as a global stage where science, biotech, and pharma converge to accelerate progress in healthy longevity.
Read the full post on Anna's LinkedIn.